MEDFORD, Mass., Feb. 23, 2017 /PRNewswire/ -- Seventh Sense Biosystems, Inc. (7SBio) announced today that a new blood collection device called TAP has received U.S. Food and Drug Administration (FDA) 510(k) clearance. The technology represents a landmark innovation in the blood collection...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]s-fda-clearance-300412276.html